ESCMID elibrary. Symposium: Acinetobacter Infections from East to West. Molecular Epidemiology Worldwide

Similar documents
Acinetobacter Outbreaks: Experience from a Neurosurgery Critical Care Unit. Jumoke Sule Consultant Microbiologist 19 May 2010

Molecular epidemiology of Acinetobacter baumannii and Acinetobacter nosocomialis in Germany over a 5-year period ( )

Multi-drug resistant Acinetobacter (MDRA) Surveillance and Control. Alison Holmes

ETX2514SUL (sulbactam/etx2514) for the treatment of Acinetobacter baumannii infections

Acinetobacter sp. isolates from emergency departments in two hospitals of South Korea

Chart showing the average height of males and females in various world countries.

Endemic and Epidemic Acinetobacter Species in a University Hospital: an 8-Year Survey

Antimicrobial resistance (EARS-Net)

Molecular Epidemiology and Insights into the Genomes of. Acinetobacter calcoaceticus - Acinetobacter baumannii complex

Dissecting the epidemiology of resistant Enterobacteriaceae and non-fermenters

WHO laboratory-based global survey on multidrug-resistant organisms (MDROs) in health care interim analysis

Overnight identification of imipenem-resistant Acinetobacter baumannii carriage in hospitalized patients

European poultry industry trends

The evolutionary epidemiology of antibiotic resistance evolution

Department of Clinical Microbiology, Nottingham University Hospitals NHS Trust, Queen s Medical Centre, Nottingham, UK

MRSA in the United Kingdom status quo and future developments

Pneumococcus: Antibiotic Resistance in the Region

MDR Acinetobacter baumannii. Has the post antibiotic era arrived? Dr. Michael A. Borg Infection Control Dept Mater Dei Hospital Malta

The challenge of growing resistance

MRSA found in British pig meat

Health Service Executive Parkgate St. Business Centre, Dublin 8 Tel:

The importance of infection control in the era of multi drug resistance

Outline. Antimicrobial resistance. Antimicrobial resistance in gram negative bacilli. % susceptibility 7/11/2010

Antibiotic resistance: the rise of the superbugs

EARS Net Report, Quarter

DR. MICHAEL A. BORG DIRECTOR OF INFECTION PREVENTION & CONTROL MATER DEI HOSPITAL - MALTA

classification of Acinetobacter baumannii clinical isolates to international clones

ORIGINAL ARTICLE /j x

Consumption of antibiotics in hospitals. Antimicrobial stewardship.

ESCMID Online Lecture Library. by author

Safe Patient Care Keeping our Residents Safe Use Standard Precautions for ALL Residents at ALL times

This document is available on the English-language website of the Banque de France

Microbiology of War Wounds AUBMC Experience

An Intrinsic Strain of Colistin-resistant Acinetobacter Isolated from a Japanese Patient

Summary of the latest data on antibiotic consumption in the European Union

Multi-Drug Resistant Gram Negative Organisms POLICY REVIEW DATE EXTENDED Printed copies must not be considered the definitive version

Witchcraft for Gram negatives

Impact of Antimicrobial Resistance on Human Health. Robert Cunney HSE HCAI/AMR Programme and Temple Street Children s University Hospital

A web-based interactive tool to explore antibiotic resistance and consumption via maps and charts

Acinetobacter Resistance in Turkish Tertiary Care Hospitals. Zeliha KOCAK TUFAN, MD, Assoc. Prof.

Clonal Diversity of Nosocomial Epidemic Acinetobacter baumannii Strains Isolated in Spain

Global Monthly October 2016

RULES & REGULATIONS EUKANUBA WORLD CHALLENGE 2019 Birmingham March 7th

Non-Susceptibility of Bacterial Pathogens Causing Hospital-Onset Pneumonia UK and Ireland,

ESBL Producers An Increasing Problem: An Overview Of An Underrated Threat

AMR epidemiological situation: ECDC update

Antimicrobial Cycling. Donald E Low University of Toronto

Epidemiological characterization and distribution of carbapenemresistant Acinetobacter baumannii clinical isolates in Italy

Food & Veterinary Office

Summary of the latest data on antibiotic consumption in the European Union

OIE Collaborating Centres Reports Activities

Vandendriessche S, Deplano A, Nonhoff C, Dodemont M, Roisin S, R De Mendonça and Denis O. Centre National de Référence Staphylococcus aureus, Belgium

Global response to antibiotic access and resistance: Stuart B. Levy, M.D. Tufts University School of Medicine Alliance for Prudent Use of Antibiotics

Int.J.Curr.Microbiol.App.Sci (2017) 6(3):

Update on Resistance and Epidemiology of Nosocomial Respiratory Pathogens in Asia. Po-Ren Hsueh. National Taiwan University Hospital

Mono- versus Bitherapy for Management of HAP/VAP in the ICU

Campylobacter infections in EU/EEA and related AMR

Carbapenemase-producing Enterobacteriaceae (CRE) T H E L A T E S T I N T H E G R O W I N G L I S T O F S U P E R B U G S

Diversity in Acinetobacter baumannii isolates from paediatric cancer patients in Egypt

MDRO in LTCF: Forming Networks to Control the Problem

Prevalence of Metallo-Beta-Lactamase Producing Pseudomonas aeruginosa and its antibiogram in a tertiary care centre

ETX2514: Responding to the global threat of nosocomial multidrug and extremely drug resistant Gram-negative pathogens

Summary of the latest data on antibiotic resistance in the European Union

«Antibiotic Stewardship» programmes & antibiotic resistance

Prof. Otto Cars. We are overconsuming a global resource. It is a collective responsibility by governments, supranational organisatons

Lindsay E. Nicolle University of Manitoba Winnipeg, CANADA

European Medicines Agency role and experience on antimicrobial resistance

by author ESCMID Online Lecture Library EUCAST The European Committee on Antimicrobial Susceptibility Testing September 2010

Longitudinal Analysis of the Temporal Evolution of Acinetobacter baumannii Strains in Ohio, USA, by Using Rapid Automated Typing Methods

AbaR7, a Genomic Resistance Island Found in Multidrug-resistant Acinetobacter baumannii Isolates in Daejeon, Korea

Monitoring gonococcal antimicrobial susceptibility

A snapshot of polymyxin use around the world South America

Nosocomial Infections: What Are the Unmet Needs

Acinetobacter species-associated infections and their antibiotic susceptibility profiles in Malaysia.

ESCMID Online Lecture Library. by author

New Opportunities for Microbiology Labs to Add Value to Antimicrobial Stewardship Programs

Quelle politique antibiotique pour l Europe? Dominique L. Monnet

TECHNICAL REPORT External quality assessment of laboratory performance European Antimicrobial Resistance Surveillance Network (EARS-Net), 2017

Foodborne Zoonotic Parasites

Antimicrobial resistance and antimicrobial consumption in Europe

Aus dem Institut für Mikrobiologie und Tierseuchen. des Fachbereichs Veterinärmedizin. der Freien Universität Berlin

Geoffrey Coombs 1, Graeme Nimmo 2, Julie Pearson 1, Samantha Cramer 1 and Keryn Christiansen 1

What is the problem? Latest data on antibiotic resistance

Antibiotic treatment in the ICU 1. ICU Fellowship Training Radboudumc

Annals of Clinical Microbiology and Antimicrobials. Open Access RESEARCH

Florida Health Care Association District 2 January 13, 2015 A.C. Burke, MA, CIC

Neisseria meningitidis ANTIMICROBIAL RESISTANCE:CURRENT SITUATION IN LATIN AMERICA AND ITS CLINICAL RELEVANCE

What does multiresistance actually mean? Yohei Doi, MD, PhD University of Pittsburgh

Quality of veterinary medicines

HEALTHCARE-ACQUIRED INFECTIONS AND ANTIMICROBIAL RESISTANCE

Multi-drug resistant microorganisms

Introduction ICAO PKD Higher Travel Security. ICAO TRIP Seminar 9 to 11th May 2016

Epidemic and Information Research and Development Monitoring and Detection Education Training International Cooperation

THE DEVELOPMENT OF A RISK BASED MEAT INSPECTION SYSTEM SANCO / 4403 / 2000

Prevention and control of antimicrobial resistance in healthcare settings: raising awareness about best practices

Received 21 June 2002/Returned for modification 23 July 2002/Accepted 24 September 2002

SUPPLEMENT ARTICLE. S114 CID 2001:32 (Suppl 2) Diekema et al.

Private Sector Perspectives IFAH (worldwide)

WHO global and regional activities on AMR and collaboration with partner organisations

Available online at ISSN No:

Transcription:

Symposium: Acinetobacter Infections from East to West Molecular Epidemiology Worldwide Harald Seifert Institut für Medizinische Mikrobiologie, Immunologie und Hygiene der Universität zu Köln 26 th ECCMID, Amsterdam, 9-12 April 2016

Twenty-three soldiers wounded in Iraq and subsequently admitted to Brooke Army Medical Center, San Antonio, Texas from March 2003 to May 2004 had wound cultures positive for Acinetobacter baumannii. Eighteen had osteomyelitis, 2 burn infection, and 3 deep wound infection. All isolates were MDR, 4 were resistant to imipenem. Davis KA et al. Emerg Infect Dis. 2005; 11:1218-24

IRAQIBACTER Acinetobacter (pronounced a-sin-ee-toe-back-ter)

Microbiology/Taxonomy of Acinetobacter (Molecular) Epidemiology of A. baumannii

v v Genus Acinetobacter : Current Taxonomy ~57 named and 5 unnamed species Courtesy A. Nemec

Genus Acinetobacter : Current Taxonomy ~57 named and 5 unnamed species A. baumannii A. pittii (DNA group 3) A. calcoaceticus A. seifertii ( Close to DNA group 13TU ) A. haemolyticus A. bereziniae (DNA group 10) A. baumannii group* A. johnsonii A. guillouiae (DNA group 11) A. junii A. nosocomialis (DNA group 13TU) A. lwoffii DNA group 13 BJ/14 TU A. parvus A. courvalinii (DNA group 14 BJ) A. radioresistens A. variabilis (DNA group 15 TU) A. schindleri DNA group 16 A. ursingii A. dispersus (DNA group 17) *Peleg et al., CMR, 2008

Identification of Acinetobacter spp. in the routine diagnostic laboratory Scheme of ~28 physiological and biochemical tests Bouvet & Grimont (1986), Gerner-Smidt et al. (1990) Not suitable for routine microbiological diagnostics Manual commercial ID systems (Api 20NE etc..) Completely unreliable Automated commercial identification systems (VITEK ) Not very reliable, but improving Molecular reference methods (rpob, gyrb, Oxa-51) Not suitable for routine microbiological diagnostics MALDI-TOF Very promising, even within the A. baumannii group

Microbiology/Taxonomy of Acinetobacter (Molecular) Epidemiology of A. baumannii

Natural habitat of Acinetobacter A. nonbaumannii: Water, soil, plants, vegetables, human skin (Baumann et al., J Bact 1968; Seifert et al. JCM, 1997; Berlau et al. JHI, 1999; Berlau et al. EJCMID, 1999; Houang et al., JCM, 2001) A. baumannii is not an ubiquitous organism A hospital-adapted pathogen The colonized patient is the reservoir In the hospital: respiratory tubing, computer keyboards, cellphones (Cefai et al., JHI 1900; Neely et al., CID 1999; Borer et al., EID 2005) Natural habitat remains to be defined (although found in body lice, pets, domestic animals, meat, and birds droplings) (La Scola, EID 2004; Belmonte, Vet Microbiol 2014; Rafei, AEM 2015; Wilharm, unpublished)

Acinetobacter: Carbapenem-resistance in invasive infections 53.1% 65.4% 5.5% 89.9% 69.7% 78.8% 87.3% 81.3% 59.1% 93.2% EARS-Net annual report 2014 77.6%

Susceptibility rates of A. baumannii group isolates to meropenem ( 2mg/L*) Region % (no.) of A. baumannii isolates susceptible, 2010-2014 2010 2011 2012 2013 2014 2010-2014 Asia 36.4 (165) 16.7 (66) - - - 30.6 (235) Europe 56.2 (1391) 49.7 (1076) 54.3 (832) 32.7 (883) 31.8 (711) 46.8 (4893) Latin America 30.9 (353) 18.2 (298) - 8.2 (61) 10.5 (105) 21.7 (828) North America 52.8 (409) 68.7 (367) 59.7 (467) 44.8 (290) 45.2 (177) 56.0 (1710) Middle East 34.4 (160) 21.9 (73) 10.9 (92) 6.2 (65) - 21.8 (390) * CLSI Breakpoint TEST Surveillance Data, IHMA, Schaumburg Illinois, USA; unpublished - courtesy Bob Badal

A. baumannii infection requires 1. a susceptible patient 2. presence of the organism (endemic or epidemic)

Chung DR et al. Am J Respir Crit Med 2011;184:1409-1417 Major organisms isolated from HAP and VAP in Asia 1 1 1 1 1 1

Transmission of A. baumannii Transmission from a common source Airborne transmission (Bernards et al., AJIC 1998) Patient-to-patient transmission Hands of hospital personnel Contamination of environmental surfaces Contamination of medical equipment Colonized patient is the primary reservoir

Outbreak of carbapenem-resistant A. baumannii carrying OXA-23 in a German university medical centre 61-year-old patient transferred from Thailand motor vehicle accident multiple During trauma the following 9 months 32 patients were found admission colonized/infected with soft-tissue with epidemic MDR A. baumannii infection and osteomyelitis to a surgical ward wound culture (02 06): Kohlenberg et al. J Med Microbiol. 2009; 58:1499-507.

Epidemiology of A. baumannii Multiple hospital outbreak within a city New York (Landman et al., ArchIM 2002) London (Turton et al., JHI 2004) Johannesburg (Marais et al., AJIC 2004) Multiple city outbreaks within a country Czech Republic (Nemec et al., JMM 2004) Southeast England (Coelho et al., JCM 2004) France (Naas et al., EID 2006) Outbreaks from hospitals in several countries in Europe van Dessel et al., Res Microbiol 2004 Towner et al., CMI 2008 Higgins et al., JAC 2010

Molecular methods for typing Acinetobacter baumannii PFGE (Seifert et al., JCM 2005) MLST (Bartual et al., JCM 2005): pubmlst.org MLST (Diancourt et al., PLoS One 2010): pasteur.fr/mlst PCR/ESI-MS (Ecker et al., JCM 2006) Sequence-group typing (Turton et al., CMI 2007) RAPD, AFLP, rep-pcr, VNTR, Oxa51-like.. Next generation sequencing (NGS WGS)

Acinetobacter baumannii infections The European (EU) Clones There was published evidence that three pan-european A. baumannii clones (lineages) are spreading in Europe (Dijkshoorn et al., JCM 1996; Nemec et al., JMM 2004; Turton et al., CMI 2007)

Acinetobacter baumannii infections The European (EU) Clones There is evidence that three pan-european A. baumannii clones (lineages) are spreading in Europe (Dijkshoorn et al., JCM 1996; Nemec et al., JMM 2004; Turton et al., CMI 2007) Unlike with MRSA, there was no estimate of the true contribution of the various EU clones to the global epidemiology of A. baumannii

Global Spread of Carbapenem-Resistant Acinetobacter baumannii (CRAb) Methods 492 carbapenem-non susceptible (MIC > 8 mg/l) A. baumannii isolates from a world-wide surveillance study (Tigecycline Evaluation and Surveillance Trial (T.E.S.T.), 2004-2006) were typed by rep-pcr (DiversiLab) to assess clonal relatedness. Results The vast majority of isolates (91%) were grouped into 8 distinct clusters (WW1 WW8) including European clones EU I, II and III. Higgins P et al. JAC 2010; 65:233-238

Acinetobacter baumannii clones Terminology issues European clones (EUI-III; Dijkshoorn et al., 1996) Worldwide clones (WW1-8; Higgins et al., 2010) Global clones (GC) International clones (IC)

IC3 IC2 IC4 IC5 IC7 IC6 IC8 IC1 IC 2 was the largest (241 isolates, 49%) and most widespread group, with isolates from USA, Honduras, Pan-Europe, Israel, India, Pakistan, China, Korea, Singapore, Taiwan, Australia and South Africa. Higgins P et al. JAC 2010; 65:233-238

Higgins PG et al. 2010. Global spread of carbapenem-resistant Acinetobacter baumannii. JAC 65:233-8 Proportion of carbapenem resistant A. baumannii clustering with the International clonal lineages (N = 492)

Higgins PG et al. 2010. Global spread of carbapenem-resistant Acinetobacter baumannii. JAC 65:233-8 Austria Bulgaria France Germany Greece Hungary Ireland Italy Latvia Poland Portugal Spain Switzerland United Kingdom Europe (n = 116) IC3 1% others 24% IC2 57% IC1 18%

Higgins PG et al. 2010. Global spread of carbapenem-resistant Acinetobacter baumannii. JAC 65:233-8 Asia (n= 45) others 13% IC2 60% IC1 27% China Korea India Pakistan Singapore Taiwan

Higgins PG et al. 2010. Global spread of carbapenem-resistant Acinetobacter baumannii. JAC 65:233-8 USA, (n = 215) IC3 11% IC5 20% IC1 5% IC2 60%

Higgins PG et al. 2010. Global spread of carbapenem-resistant Acinetobacter baumannii. JAC 65:233-8 Argentina Brazil Chile Colombia Honduras Mexico Puerto Rico Venezuela South and Central America, n = 93 others 43% IC1 2% IC4 18% IC5 37%

99% of isolates were IC2 (China) 91% of isolates were IC2 (Japan) 2013; 57:1069-72 85% of isolates were IC2 (USA) 71% of isolates were IC2 (Poland) 70% of isolates were IC2 (Brasil) 71% of isolates were IC2 (Australia)

Randomized, open label, multicenter, non-inferiority phase IV clinical trial to compare safety and efficacy of colistin vs. meropenem in ventilator-associated pneumonia (VAP). Patients were randomized to receive colistin 3 MU iv. / 8 h or meropenem 1 g iv / 8 h. Each group will receive levofloxacin 500 mg iv/12 h in addition to the treatment. At study close on October 13, 2015, 232 patients were enrolled in 35 centers in Greece, Italy and Spain (Principal Investigator: JM Cisneros, Sevilla, Spain).

Background: Whole genome sequencing (WGS) will revolutionise bacterial strain typing but data analysis is still a challenge. Methods: WGS was employed to define and evaluate a core genome multilocus sequence typing (cgmlst) scheme for A. baumannii using Ridom SeqSphere+ software. Using genomes from NCBI as well as representative isolates belonging to the 8 previously described A. baumannii ICs, a core genome of 2,390 alleles was defined. This was then employed against a total of 56 A. baumannii isolates, previously typed by PFGE and linked to hospital outbreaks. Results: Good correlation between PFGE and cgmlst clustering was found, with 0-8 allelic differences within a pulsotype, and 40-2,166 differences between pulsotypes. The highest number of allelic differences was between the isolates representing different ICs. Higgins PG, Prior K, Harmsen D, Seifert H. Defining and evaluating a core genome multilocus typing scheme for whole-genome sequence-based typing of Acinetobacter baumannii (submitted)

IC8 Minimum spanning tree based on cgmlst allelic profiles of all currently known A. baumannii ICs IC7 2103 1782 2073 2121 IC2 IC6 2071 2069 IC3 1910 2056 IC5 IC4 IC1 Higgins PG, et al., submitted

We are witnessing the continuing spread of carbapenem resistant A. baumannii This spread is caused by a few successful clonal lineages International clonal lineage 2 (IC2) is the most prevalent worldwide and obviously still increasing reppcr is a robust typing method that correlates well with MLST Conclusions cgmlst is a promising molecular typing method

11 th Acinetobacter 2017 September 20-22, 2017 Sevilla, Spain Alvaro Pascual and Jerónimo Pachón